Characterization of the specific CD4+ T cell response against the F Protein during chronic hepatitis C virus infection

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Gao, De Yong ^a,b   Jin, Gen Di ^a   Yao, Bi Lian ^a   Zhang, Dong Hua ^a   Gu, Lei Lei ^a   Lu, Zhi Meng ^a   Gong, Qiming ^a   Lone, Yu Chun ^c   Deng, Qiang ^d   Zhang, Xin Xin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c HÔPITAL PAUL BROUSSE   (France)

^d INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATE READING FRAME PROTEIN; DNA VACCINE; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; HLA DP4 ANTIGEN; HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS FUSION PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOCHEMISTRY; DISEASE MODEL; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; TRANSGENIC MOUSE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CYTOLOGY; METABOLISM; MOLECULAR GENETICS; MONONUCLEAR CELL; SPLEEN; VIROLOGY;

HEPATITIS C VIRUS; MUS MUSCULUS;

AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES; HEPACIVIRUS; HEPATITIS C; HLA ANTIGENS; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; SPLEEN; VIRAL FUSION PROTEINS;

EID: 78650119643     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014237     Document Type: Article

References (33)

1. Cohen J (1999) The scientific challenge of hepatitis C. Science 285: 26-30.
2. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52.
3. Berzofsky JA, Ahlers JD, Janik J, Morris J, Oh S, et al. (2004) Progress on new vaccine strategies against chronic viral infections. J Clin Invest 114: 450-462.
4. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH (2000) Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132: 296-305.
5. Gremion C, Cerny A (2005) Hepatitis C virus and the immune system: a concise review. Rev Med Virol 15: 235-268.
6. Day CL, Walker BD (2003) Progress in defining CD4 helper cell responses in chronic viral infections. J Exp Med 198: 1773-1777.
7. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, et al. (1996) Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98: 706- 714.
8. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, et al. (1995) Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007.
9. Eckels DD, Wang H, Bian TH, Tabatabai N, Gill JC (2000) Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection. Immunol Rev 174: 90-97.
10. Shoukry NH, Cawthon AG, Walker CM (2004) Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 58: 391-424.
11. 4+ T cells. J Exp Med 184: 863-871.
12. Planz O, Ehl S, Furrer E, Horvath E, Brundler MA, et al. (1997) A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci U S A 94: 6874-6879.
13. Boulant S, Becchi M, Penin F, Lavergne JP (2003) Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem 278: 45785-45792.
14. Branch AD, Stump DD, Gutierrez JA, Eng F, Walewski JL (2005) The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others. Semin Liver Dis 25: 105-117.
15. Vassilaki N, Mavromara P (2009) The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product. IUBMB Life 61: 739-752.
16. Komurian-Pradel F, Rajoharison A, Berland JL, Khouri V, Perret M, et al. (2004) Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology 40: 900-909.
17. Gao DY, Zhang XX, Hou G, Jin GD, Deng Q, et al. (2008) Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin. J Clin Microbiol 46: 3746-3751.
18. Mancini-Bourgine M, Bayard F, Soussan P, Deng Q, Lone YC, et al. (2007) Hepatitis B virus splice-generated protein induces T-cell responses in HLAtransgenic mice and hepatitis B virus-infected patients. J Virol 81: 4963-4972.
19. Bain C, Parroche P, Lavergne JP, Duverger B, Vieux C, et al. (2004) Memory Tcell- mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J Virol 78: 10460-10469.
20. Drouin C, Lamarche S, Bruneau J, Soudeyns H, Shoukry NH (2010) Cellmediated immune responses directed against hepatitis C virus (HCV) alternate reading frame protein (ARFP) are undetectable during acute infection. J Clin Virol 47: 102-103.
21. Pascolo S (2005) HLA class I transgenic mice: development, utilisation and improvement. Expert Opin Biol Ther 5: 919-938.
22. Singh R, Kaul R, Kaul A, Khan K (2007) A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 13: 1770-1787.
23. Barrett S, Ryan E, Crowe J (1999) Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J Hepatol 30: 979-983.
24. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC (1997) Detection of type 2- like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25: 449-458.
25. Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, et al. (1997) CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 159: 1012-1018.
26. Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, et al. (2003) Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37: 1189-1198.
27. 4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology 35: 190-198.
28. 8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 37: 577-589.
29. Semmo N, Krashias G, Willberg C, Klenerman P (2007) Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection. J Viral Hepat 14: 492-502.
30. Mancini M, Davis H, Tiollais P, Michel ML (1996) DNA-based immunization against the envelope proteins of the hepatitis B virus. J Biotechnol 44: 47-57.
31. Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyano K, et al. (1984) Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. Gann 75: 151-158.
32. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289-293.
33. 4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76: 12584-12595.